Page 94 - Read Online

Muttin et al. Mini-invasive Surg 2019;3:10 I http://dx.doi.org/10.20517/2574-1225.2018.005 Page 5 of 5

12. McIntosh AG, Ristau BT, Ruth K, Jennings R, Ross E, et al. Active surveillance for localized renal masses: tumor growth, delayed
intervention rates, and > 5-yr clinical outcomes. Eur Urol 2018;74:157-64.
13. Lane BR, Abouassaly R, Gao T, Weight CJ, Hernandez AV, et al. Active treatment of localized renal tumors may not impact overall
survival in patients aged 75 years or older. Cancer 2010;116:3119-26.
14. Kutikov A, Egleston BL, Canter D, Smaldone MC, Wong YN, et al. Competing risks of death in patients with localized renal cell
carcinoma: a comorbidity based model. J Urol 2012;188:2077-83.
15. Pierorazio PM, Johnson MH, Patel HD, Sozio SM, Sharma R, et al. Management of renal masses and localized renal cancer: systematic
review and meta-analysis. J Urol 2016;196:989-99.
16. Larcher A, Fossati N, Tian Z, Boehm K, Meskawi M, et al. Prediction of complications following partial nephrectomy: implications for
ablative techniques candidates. Eur Urol 2016;69:676-82.
17. Larcher A, Trudeau V, Dell’Oglio P, Tian Z, Boehm K, et al. Prediction of competing mortality for decision-making between surgery or
observation in elderly patients with T1 kidney cancer. Urology 2017;102:130-7.
18. Patel N, Cranston D, Akhtar MZ, George C, Jones A, et al. Active surveillance of small renal masses offers short-term oncological
efficacy equivalent to radical and partial nephrectomy. BJU Int 2012;110:1270-5.
19. Alam R, Patel HD, Osumah T, Srivastava A, Gorin MA, et al. Comparative effectiveness of management options for patients with small
renal masses: a prospective cohort study. BJU Int 2018;351:1296.
20. Ristau BT, Kutikov A, Uzzo RG, Smaldone MC. Active surveillance for small renal masses: when less is more. Eur Urol Focus
2016;2:660-8.
21. Motzer RJ. Kidney Cancer, Version 4.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2018:1-59.
22. Campbell S, Uzzo RG, Allaf ME, Bass EB, Cadeddu JA, et al. Renal mass and localized renal cancer: AUA guideline. J Urol
2017;198:520-9.
23. Finelli A, Ismaila N, Bro B, Durack J, Eggener S, et al. Management of small renal masses: american society of clinical oncology
clinical practice guideline. J Clin Oncol 2017;35:668-80.
24. Zini L, Patard JJ, Capitanio U, Crépel M, la Taille De A, et al. Cancer-specific and non-cancer-related mortality rates in European
patients with T1a and T1b renal cell carcinoma. BJU Int 2009;103:894-8.
25. Zini L, Patard JJ, Capitanio U, Mejean A, Villers A, et al. The use of partial nephrectomy in European tertiary care centers. Eur J Surg
Oncol 2009;35:636-42.
26. Van Poppel H, Da Pozzo L, Albrecht W, Matveev V, Bono A, et al. A prospective, randomised EORTC intergroup phase 3 study
comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur
Urol 2011;59:543-52.
27. Sun M, Bianchi M, Hansen J, Trinh QD, Abdollah F, et al. Chronic kidney disease after nephrectomy in patients with small renal
masses: a retrospective observational analysis. Eur Urol 2012;62:696-703.
28. Eckardt KU, Coresh J, Devuyst O, Johnson RJ, Köttgen A, et al. Evolving importance of kidney disease: from subspecialty to global
health burden. Lancet 2013;382:158-69.
29. Scosyrev E, Messing EM, Sylvester R, Campbell S, Van Poppel H. Renal function after nephron-sparing surgery versus radical
nephrectomy: results from EORTC randomized trial 30904. Eur Urol 2014;65:372-7.
30. Capitanio U, Larcher A, Terrone C, Antonelli A, Volpe A, et al. End-stage renal disease after renal surgery in patients with normal
preoperative kidney function: balancing surgical strategy and individual disorders at baseline. Eur Urol 2016;70:558-61.
31. Huang WC, Elkin EB, Levey AS, Jang TL, Russo P. Partial nephrectomy versus radical nephrectomy in patients with small renal
tumors--is there a difference in mortality and cardiovascular outcomes? J Urol 2009;181:55-61; discussion 61-2.
32. Capitanio U, Terrone C, Antonelli A, Minervini A, Volpe A, et al. Nephron-sparing techniques independently decrease the risk of
cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function.
European Urology 2015;67:683-9.
33. Sun M, Trinh QD, Bianchi M, Hansen J, Hanna N, et al. A non-cancer-related survival benefit is associated with partial nephrectomy.
Eur Urol 2012;61:725-31.
34. Kim SP, Thompson RH, Boorjian SA, Weight CJ, Han LC, et al. Comparative effectiveness for survival and renal function of partial and
radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol 2012;188:51-7.
35. Larcher A, Capitanio U, Terrone C, Volpe A, De Angelis P, et al. Elective nephron sparing surgery decreases other cause mortality
relative to radical nephrectomy only in specific subgroups of patients with renal cell carcinoma. J Urol 2016;196:1008-13.
36. Peyronnet B, Seisen T, Oger E, Vaessen C, Grassano Y, et al. Comparison of 1800 robotic and open partial nephrectomies for renal
tumors. Ann Surg Oncol 2016;23:4277-83.
37. Larcher A, Capitanio U, De Naeyer G, Fossati N, D’Hondt F, et al. Is robot-assisted surgery contraindicated in the case of partial
nephrectomy for complex tumours or relevant comorbidities? A comparative analysis of morbidity, renal function, and oncologic
outcomes. Eur Urol Oncol 2018;1:61-8.
38. Pierorazio PM, Patel HD, Feng T, Yohannan J, Hyams ES, et al. Robotic-assisted versus traditional laparoscopic partial nephrectomy:
comparison of outcomes and evaluation of learning curve. Urology 2011;78:813-9.
39. Leow JJ, Heah NH, Chang SL, Chong YL, Png KS. Outcomes of robotic versus laparoscopic partial nephrectomy: an updated meta-
analysis of 4,919 patients. J Urol 2016;196:1371-7.
40. Larcher A, Muttin F, Peyronnet B, De Naeyer G, Khene ZE, et al. The learning curve for robot-assisted partial nephrectomy: impact of
surgical experience on perioperative outcomes. Eur Urol 2019;75:253-6.